Tag Archives: PRXL

Hot Insurance Stocks To Own Right Now

RenaissanceRe Holdings (RNR) is a global provider of reinsurance, as well as various types of insurance and related services. The company was founded in 1993 and is headquartered in Bermuda, notes Jack Adamo, editor of Insiders Plus.

The company operates through three segments: Catastrophe Reinsurance, Specialty Reinsurance, and Lloyd’s segments (Lloyd’s of London).

Within these segments are covered property claims, automobile liability, catastrophe exposed workers’ compensation, cyber liability, directors and officers liability, environmental liability, medical malpractice, and professional indemnity among many others types.

RenaissanceRe Holdings Ltd. 5.375% Series E Preference Shares (RNR-E) are selling at a 6.7% discount to their redemption price, giving them a current yield of 5.74% and an annualized total return of 9.94% if they are redeemed in June of 2018, when they are eligible to be redeemed by the company.

Hot Insurance Stocks To Own Right Now: Caladrius Biosciences, Inc.(CLBS)

Advisors’ Opinion:

  • [By Shane Hupp]

    News coverage about Caladrius Biosciences (NASDAQ:CLBS) has trended somewhat positive on Friday, according to Accern Sentiment Analysis. The research group identifies negative and positive press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Caladrius Biosciences earned a coverage optimism score of 0.17 on Accern’s scale. Accern also gave news headlines about the biotechnology company an impact score of 45.4362129030389 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Caladrius Biosciences (CLBS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Caladrius Biosciences (CLBS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Insurance Stocks To Own Right Now: Ideal Power Inc.(IPWR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Here are some of the news headlines that may have effected Accern Sentiment’s rankings:

    Get Ideal Power alerts:

    Ideal Power (IPWR) Expected to Announce Quarterly Sales of $390,000.00 (americanbankingnews.com) -$0.15 EPS Expected for Ideal Power (IPWR) This Quarter (americanbankingnews.com) Ideal Power Receives 1.1 Megawatt Purchase Order for its SunDial™ Plus Inverters (investingnews.com) Ideal Power Receives 1.1 Megawatt Purchase Order for its SunDial™ Plus Inverters from NEXTracker for One of the Largest Solar-and-Storage Installations in Iowa (finance.yahoo.com)

    A number of equities analysts have commented on the stock. Zacks Investment Research raised shares of Ideal Power from a “hold” rating to a “buy” rating and set a $1.50 price target for the company in a research note on Wednesday, January 10th. HC Wainwright reissued a “buy” rating and issued a $4.00 price target on shares of Ideal Power in a research note on Wednesday, March 7th. Roth Capital reissued a “hold” rating and issued a $1.00 price target on shares of Ideal Power in a research note on Wednesday, March 7th. Finally, B. Riley cut shares of Ideal Power from a “buy” rating to a “neutral” rating and cut their price target for the stock from $5.00 to $2.50 in a research note on Wednesday, March 7th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the stock. Ideal Power currently has a consensus rating of “Hold” and a consensus price target of $3.00.

  • [By Logan Wallace]

    Ideal Power (NASDAQ: IPWR) and Hollysys Automation Technologies (NASDAQ:HOLI) are both small-cap industrial products companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, profitability, risk and earnings.

  • [By Max Byerly]

    News articles about Ideal Power (NASDAQ:IPWR) have trended somewhat positive recently, according to Accern Sentiment. Accern identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Ideal Power earned a coverage optimism score of 0.12 on Accern’s scale. Accern also gave press coverage about the industrial products company an impact score of 47.3748047378114 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Ideal Power (IPWR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Insurance Stocks To Own Right Now: PAREXEL International Corporation(PRXL)

Advisors’ Opinion:

  • [By Logan Wallace]

    News headlines about PAREXEL International (NASDAQ:PRXL) have trended somewhat positive on Tuesday, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. PAREXEL International earned a news impact score of 0.18 on Accern’s scale. Accern also gave press coverage about the medical research company an impact score of 49.4978250148766 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 5 Safest Stocks To Own Right Now

Numis Securities cut shares of Safestore (LON:SAFE) to a hold rating in a report published on Thursday morning.

Several other research analysts also recently issued reports on the stock. Liberum Capital reissued a buy rating and set a GBX 560 ($7.46) price objective on shares of Safestore in a research report on Thursday, February 22nd. Peel Hunt reissued a hold rating on shares of Safestore in a research report on Thursday, April 5th. Three analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The company has an average rating of Buy and an average target price of GBX 540.83 ($7.20).

Get Safestore alerts:

Safestore opened at GBX 556.50 ($7.41) on Thursday, MarketBeat Ratings reports. Safestore has a 1-year low of GBX 360 ($4.79) and a 1-year high of GBX 528 ($7.03).

Top 5 Safest Stocks To Own Right Now: First Financial Northwest Inc.(FFNW)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on First Financial Northwest (FFNW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on First Financial Northwest (FFNW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Safest Stocks To Own Right Now: Coinstar Inc.(CSTR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Capstar Financial (NASDAQ: CSTR) and Mercantile Bank (NASDAQ:MBWM) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, dividends and risk.

  • [By Joseph Griffin]

    Shares of Capstar Financial Holdings Inc (NASDAQ:CSTR) have been assigned an average rating of “Hold” from the five research firms that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $19.75.

Top 5 Safest Stocks To Own Right Now: Celgene Corporation(CELG)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Stock No. 1: The first one up, alphabetically, is Celgene (NASDAQ:CELG). The ticker symbol is CELG. Celgene, two years ago, was at $101 a share. Celgene, as of Monday’s market close was down to $84.57. So, not such a great stock pick of mine. Celgene down 16%. The market up 30%. So, we’re going to have to log a minus 46% to start this review of my stocks from five years ago, as Celgene has dropped a little and the market, as we’ve already established, has done quite well.

  • [By ]

    Cramer was bearish on Xilinx (XLNX) , Celgene (CELG) , Exelixis (EXEL) , Moneygram (MGI) , Monster Beverage (MNST) , SunCoke Energy Partners (SXCP) and Mattel (MAT) .

  • [By Logan Wallace]

    Celgene (NASDAQ:CELG) announced that its Board of Directors has approved a stock repurchase program, which allows the company to buyback $3.00 billion in shares on Thursday, May 24th. This buyback authorization allows the biopharmaceutical company to buy up to 5.4% of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s board of directors believes its shares are undervalued.

  • [By Keith Speights]

    There’s room for debate, of course. But in my view, three deals especially stand out. Here’s why I rank Celgene’s (NASDAQ:CELG) buyout of Juno Therapeutics, Novartis’ (NYSE:NVS) acquisition of AveXis, and Roche’s (NASDAQOTH:RHHBY) purchase of Foundation Medicine (NASDAQ:FMI) as the best biotech acquisitions of 2018 (so far).

  • [By Paul Ausick]

    Celgene Corp. (NASDAQ: CELG) dropped about 1.8% Friday to post a new 52-week low of $78.51. Shares closed at $79.98 on Thursday and the stock’s 52-week high is $147.17. Volume of around 5.4 million shares was about 20% below the daily average. The company was one of several named Thursday in an FDA report of drugmakers who may be illegally blocking delaying access to cheaper generic copies of brand-name drugs.

  • [By Ethan Ryder]

    Sumitomo Mitsui Trust Holdings Inc. increased its holdings in Celgene (NASDAQ:CELG) by 3.9% during the first quarter, HoldingsChannel.com reports. The fund owned 2,379,884 shares of the biopharmaceutical company’s stock after buying an additional 89,641 shares during the period. Sumitomo Mitsui Trust Holdings Inc.’s holdings in Celgene were worth $212,309,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Top 5 Safest Stocks To Own Right Now: PAREXEL International Corporation(PRXL)

Advisors’ Opinion:

  • [By Logan Wallace]

    News headlines about PAREXEL International (NASDAQ:PRXL) have trended somewhat positive on Tuesday, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. PAREXEL International earned a news impact score of 0.18 on Accern’s scale. Accern also gave press coverage about the medical research company an impact score of 49.4978250148766 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 5 Safest Stocks To Own Right Now: ZIOPHARM Oncology Inc(ZIOP)

Advisors’ Opinion:

  • [By Keith Speights]

    Over the last 12 months, bluebird bio (NASDAQ:BLUE) stock has more than doubled. During the same period, Ziopharm Oncology’s (NASDAQ:ZIOP) share price has tumbled over 30%. That’s the past, though. Which of these two clinical-stage biotech stocks is the better pick for investors now?

  • [By Keith Speights]

    If you like putting money into the beaten-down stocks of clinical-stage biotechs, Ziopharm Oncology (NASDAQ:ZIOP) and Celldex Therapeutics (NASDAQ:CLDX) might warrant a look. Ziopharm’s share price has dropped more than 25% so far in 2018, while Celldex stock has plunged more than 80%.

  • [By Paul Ausick]

    Ziopharm Oncology Inc. (NASDAQ: ZIOP) dropped more than 10% Tuesday to post a 52-week low of $3.77 after closing at $4.20 on Monday. The 52-week high is $7.88. Volume was around 3.7 million, more than double the daily average. The company reported Tuesday on progress of two platforms it is developing and investors did not like what they heard.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) fell 42 percent to $2.25 in pre-market trading after dropping 31.45 percent on Thursday. Stellar Biotechnologies priced 2.075 million units at price of $2.65 per unit.
    Symantec Corporation (NASDAQ: SYMC) shares fell 25.2 percent to $21.82 in pre-market trading. Symantec reported better-than-expected earnings for its fourth quarter, but issued weak second-quarter guidance.
    AGM Group Holdings Inc. (NASDAQ: AGMH) shares fell 9.5 percent to $10 in pre-market trading after surging 7.79 percent on Thursday.
    ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) fell 8.9 percent to $4.11 in pre-market trading after the company posted wider-than-expected Q1 loss.
    Redfin Corporation (NASDAQ: RDFN) fell 8.6 percent to $21.00 in pre-market trading after reporting Q1 results.
    Geron Corporation (NASDAQ: GERN) fell 8.3 percent to $3.33 in pre-market trading. Geron posted a Q1 loss of $0.04 per share.
    Talend S.A. (NASDAQ: TLND) shares fell 6 percent to $56 in pre-market trading after reporting Q1 results.
    Flotek Industries, Inc. (NYSE: FTK) fell 5.4 percent to $3.54 in pre-market trading after dropping 2.35 percent on Thursday.
    Halozyme Therapeutics, Inc. (NASDAQ: HALO) fell 5.1 percent to $18.95 in pre-market trading after reporting Q1 results.
    Yelp Inc. (NYSE: YELP) shares fell 4.9 percent to $45.40 in pre-market trading. Yelp reported stronger-than-expected results for its first quarter on Thursday.
    Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) shares fell 3.3 percent to $7.50 in pre-market trading after dropping 4.32 percent on Thursday

  • [By Keith Speights]

    Ziopharm Oncology Inc. (NASDAQ:ZIOP) shareholders have been on a roller coaster ride this year. The stock soared 16% in May, but the ride promptly went downhill in June, with the biotech’s share price dropping more than 10%. The first four months of 2018 featured more of the same up-and-down action.

  • [By Todd Campbell]

    After disclosing that the Food and Drug Administration is asking for more information before signing off on a phase 1 study of its “Sleeping Beauty” CAR-T for leukemia and lymphoma, shares in Ziopharm Oncology (NASDAQ:ZIOP) were tumbling 17.7% at 3 p.m. EDT today.

Top Heal Care Stocks To Invest In Right Now

To those who are following my articles for AT&T (NYSE:T), a company I have been long for a couple years now, I apologize for not coming out with a more timely article for second-quarter results. In any case, AT&T did report its second quarter earnings about a month ago. In my last article on AT&T, written July 25th, I said that it just wasn’t yet time to sell shares. At the time shares were at $43.11, and I intended to consider selling half my remaining shares $44 per share or higher. Shares had been grinding higher since January, and so I felt that I’d get another chance to sell at $44 soon enough.

Click to enlarge

Top Heal Care Stocks To Invest In Right Now: TechTarget, Inc.(TTGT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on TechTarget (TTGT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on TechTarget (TTGT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    TechTarget (NASDAQ:TTGT) Director Leonard P. Forman sold 63,862 shares of the business’s stock in a transaction dated Tuesday, May 15th. The shares were sold at an average price of $23.59, for a total transaction of $1,506,504.58. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

Top Heal Care Stocks To Invest In Right Now: PAREXEL International Corporation(PRXL)

Advisors’ Opinion:

  • [By Logan Wallace]

    News headlines about PAREXEL International (NASDAQ:PRXL) have trended somewhat positive on Tuesday, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. PAREXEL International earned a news impact score of 0.18 on Accern’s scale. Accern also gave press coverage about the medical research company an impact score of 49.4978250148766 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top Heal Care Stocks To Invest In Right Now: Magellan Midstream Partners L.P.(MMP)

Advisors’ Opinion:

  • [By ]

    Cramer and the AAP team are looking for opportunities to trim stocks into strength based out of discipline. That means trimming Magellan Midstream Partners (MMP) . Find out what they’re telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

  • [By Shane Hupp]

    Fayez Sarofim & Co boosted its stake in Magellan Midstream Partners, L.P. (NYSE:MMP) by 14.0% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 13,372 shares of the pipeline company’s stock after purchasing an additional 1,644 shares during the period. Fayez Sarofim & Co’s holdings in Magellan Midstream Partners were worth $780,000 at the end of the most recent quarter.

  • [By Reuben Gregg Brewer]

    The midstream partnership sector is deeply out of favor today, despite the fact that these companies provide vital services moving and processing oil and natural gas. For conservative investors, Enterprise Products Partners L.P. (NYSE:EPD) and Magellan Midstream Partners, L.P. (NYSE:MMP) are two high-yield stocks that appear to be on sale today, still off roughly 30% and 20% from their 2014 highs, respectively. Here’s what you need to know to decide if Enterprise or Magellan is the better buy for you.

Top Heal Care Stocks To Invest In Right Now: Taylor Morrison Home Corporation(TMHC)

Advisors’ Opinion:

  • [By ]

    Higher rates can hurt stocks of companies like homebuilders, which rely on affordable mortgage rates for their customers. “Nobody trusts the homebuilders past the day they report because the litany is always: ‘This is the last good quarter when it comes to Lennar (LEN) , Toll Brothers (TOL) , D.R. Horton (DHI) , Taylor Morrison (TMHC) and PulteGroup (PHM) .'”

  • [By Evan Niu, CFA]

    Shares of AV Homes (NASDAQ:AVHI) have soared today, up by 29% as of 1:40 p.m. EDT, after the company announcedit was being acquired. Larger homebuilder Taylor Morrison Home Corporation (NYSE:TMHC) is scooping up AV Homes in a $1 billion deal.

  • [By ]

    In his second “Executive Decision” segment, Cramer sat down with Sheryl Palmer, chairman, president and CEO of Taylor Morrison Homes (TMHC) , for a read on the state of the housing market.

Top Heal Care Stocks To Invest In Right Now: NBT Bancorp Inc.(NBTB)

Advisors’ Opinion:

  • [By Ethan Ryder]

    NBT Bancorp (NASDAQ:NBTB) was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating in a note issued to investors on Saturday.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on NBT Bancorp (NBTB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on NBT Bancorp (NBTB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Heal Care Stocks To Invest In Right Now: QCR Holdings Inc.(QCRH)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Shares of QCR Holdings, Inc. (NASDAQ:QCRH) have been assigned a consensus recommendation of “Buy” from the seven research firms that are currently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and five have issued a buy rating on the company. The average 1 year price target among brokerages that have covered the stock in the last year is $53.60.

  • [By Shane Hupp]

    BidaskClub lowered shares of QCR (NASDAQ:QCRH) from a hold rating to a sell rating in a research note published on Wednesday.

    Separately, ValuEngine raised shares of QCR from a hold rating to a buy rating in a research report on Friday, March 2nd. One research analyst has rated the stock with a sell rating, one has given a hold rating and five have given a buy rating to the stock. QCR has an average rating of Buy and an average price target of $53.60.